Efficacy and Safety Study of PGA (Poly-gamma Glutamic Acid) for Cervical Intraepithelial Neoplasia
The purpose of this study is to determine the efficacy and the safety of PGA(Poly-gamma Glutamic Acid) for the the fertile women with Cervical Intraepithelial Neoplasia (CIN1).
Cervical Intraepithelial Neoplasia
DRUG: Poly-gamma Glutamic Acid|DRUG: Placebo
Regression rate, Regression rate will be assessed at the time of screening and 12 weeks. Regression means the change from the stage of CIN1 to normal., up to 12 weeks
Reid Colposcopic Index, Reid Colposcopic Index will be assessed at the time of screening and 12 weeks., up to 12 weeks|Pap smear test, Result of Pap smear test will be assessed at the time of screening and 12 weeks., up to 12 weeks|HPV (Human Papilloma Virus) DNA Test, Result of HPV (Human Papilloma Virus) DNA Test will be assessed at the time of screening and 12 weeks., up to 12 weeks|HPV (Human Papilloma Virus) Hybrid CaptureII Test, Result of HPV (Human Papilloma Virus) Hybrid CaptureII Test will be assessed at the time of screening and 12 weeks., up to 12 weeks|NK (Natural Killer) Cell Activity, Result of NK (Natural Killer) Cell Activity will be assessed at the time of baseline (0day), 4 weeks, 8 weeks and 12 weeks., up to 12 weeks|Peripheral Blood Mononuclear Cells (PBMCs)Test, Result of Peripheral Blood Mononuclear Cells (PBMCs) Test will be assessed at the time of baseline (0day), 4 weeks, 8 weeks and 12 weeks., up to 12 weeks
Adverse Events, Adverse events will be monitored for 12 weeks., up to 12 weeks|Vital Signs, Vital signs will be monitored for 12 weeks., up to 12 weeks|Laboratory Tests, Result of laboratory tests will be assessed at screening., up to 12 weeks
This study is to compare the regression rate of Cervical Intraepithelial Neoplasia (CIN1) between the treatment group and the control group.

The treatment group will be administered with PGA (Poly-gamma Glutamic Acid) for 4 weeks followed by 8 weeks observation.

The control group will be observed for 12 weeks without any comparator.